Form 8-K - Current report:
SEC Accession No. 0001564590-21-051444
Filing Date
2021-10-21
Accepted
2021-10-21 16:16:34
Documents
13
Period of Report
2021-10-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pstv-8k_20211021.htm   iXBRL 8-K 31602
2 EX-99.1 pstv-ex991_6.htm EX-99.1 429312
  Complete submission text file 0001564590-21-051444.txt   610626

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pstv-20211021.xsd EX-101.SCH 5717
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20211021_lab.xml EX-101.LAB 19335
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20211021_pre.xml EX-101.PRE 11510
6 EXTRACTED XBRL INSTANCE DOCUMENT pstv-8k_20211021_htm.xml XML 3548
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 211337194
SIC: 3841 Surgical & Medical Instruments & Apparatus